-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Rain Oncology Inc. annual/quarterly Depreciation history and growth rate from Q1 2021 to Q1 2022.
- Rain Oncology Inc. Depreciation for the quarter ending March 31, 2022 was $22M, a 46.7% increase year-over-year.
- Rain Oncology Inc. annual Depreciation for 2022 was $100K, unchanged from 2021.
- Rain Oncology Inc. annual Depreciation for 2021 was $100K, unchanged from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)